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416a Tuesday, March 8, 2011Consequently, we investigate the role of kinases/phosphatases and cytoskeleton
modulators (colchicine and cytochalasin D) on RyR-mediated Ca2þ leak from
SR microsomes as well as on coupled RyR1. We also investigated role of
FKBP12 in coupled RyR1 gating by adding FKBP12 to partially coupled
RyR1 or rapamycin to coupled RyR1 in planar lipid bilayers. Our results sug-
gest the RyR1-RyR1 interactions that are essential for coupled gating were not
significantly affected by addition of kinases/phosphatases, cytoskeleton modu-
lators or the addition/removal of FKBP12 by rapamycin. Yet, some of the
agents affected the overall activity of the RyR1. (Supported by NIH R01
GM078665).
2251-Pos Board B237
CGP37157 is an Inhibitor of the Sarcoplasmic Reticulum Calcium ATPase
and an Activator of Ryanodine Receptors in Striated Muscle
Jake T. Neumann, Paula L. Diaz-Sylvester, Sidney Fleischer,
Julio A. Copello.
CGP-37157 (CGP), a benzothiazepine derivative of clonazepam, is commonly
utilized as a blocker of the mitochondrial Naþ/Ca2þ exchanger. Yet, evidence
suggests that CGP could also affect other targets, such as L-type Ca2þ chan-
nels and plasmalemma Naþ/Ca2þ exchanger. Here, we tested the possibility of
a direct modulation of ryanodine receptors (RyR) and/or sarcoplasmic reticu-
lum (SR) Ca2þ stimulated ATPase (SERCA) by CGP. SERCA activity was
measured in SR microsomes with a ATP-ase activity assay or Ca2þ loading
in presence of ruthenium red (RyR blocker). The effects of CGP on RyR ac-
tivity were performed in SR microsomes with a Ca2þ leak assay or after re-
constitution of the channels into planar lipid bilayers. CGP inhibited
SERCA-mediated Ca2þ uptake of cardiac and skeletal SR microsomes
(IC50’s = 6.6 and 9.9 mM, respectively). The CGP effects on SERCA activity
correlated with a decreased Vmax of ATPase activity of SERCA-enriched skel-
etal SR fractions without an apparent change in Km. CGP (R 5 mM) also in-
creased RyR-mediated Ca2þ leak from skeletal SR microsomes. Planar bilayer
studies confirmed that both cardiac and skeletal RyR are directly activated by
CGP (EC50’s = 9.4 and 12.0 mM, respectively). In summary, we found that
CPG inhibits SERCA and activates RyR channels. Hence, the action of
CGP on cellular Ca2þ homeostasis reported in the literature of cardiac, skel-
etal muscle as well as other non muscle systems requires further analysis to
take into account the contribution of all CGP-sensitive Ca2þ transporters.
(Supported by NIH R01 GM078665).
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Tetracaine is a Potent Inhibitor of SR Ca Leak in Ventricular Cardiac
Myocytes
Stephen Shonts.
Tetracaine is commonly used to inhibit RyR-dependent SR Ca leak, however
ability to do so in intact cardiac myocytes has not been fully characterized.
In single RyR channel bilayer a significant portion of leak would not be in-
hibited even by low millimolar concentrations of tetracaine. In this study we
investigated the effectiveness of tetracaine on RYR-dependent SR Ca leak in
ventricular myocytes. Experiments were performed in isolated rabbit myo-
cytes loaded with fluo-4. Myocytes were perfused with 2mM Ca NT with
200mM caffeine in order to increase basal SR Ca leak in the presence of
varying concentrations of tetracaine (1, 10, 30, 100mM). Myocytes were
then rapidly perfused with 0 Na, 0 Ca NT with 1mM tetracaine following
washout with same solution but with varying amounts of tetracaine. SR
Ca leak was quantified as the shift of Ca from the cytosol to the SR upon
blockage of the RyR with high tetracaine. The EC50 for tetracaine is signif-
icantly reduced in intact myocytes compared to single RyR channel. Among
the potential explanations for this effect is the possibility that Ca flux regu-
lation makes the RyR clusters in the SR junction more sensitive to blockage
of release.
2253-Pos Board B239
Tetracaine Inhibits RyRs by Three Mechanisms
Derek R. Laver, Dirk F. vanHelden.
Tetracaine is a tertiary amine local anaesthetic (pKa = 8.5) which induces
closures in RyRs. Tetracaine has been extensively used to study the role of
the SR Ca2þ fluxes in Ca2þ handling in muscle cells. We use single channel
recording of rabbit skeletal and sheep cardiac RyRs in lipid bilayers to iden-
tify three mechanisms for tetracaine inhibition. First, luminal and cytoplasmic
tetracaine induce closed events (~100 ms- slow mechanism). Cytoplasmic/lu-
minal competition indicates a common site for cytoplasmic and luminal ac-
tion. The binding rate decreases with increasing RyR open probability,consistent with a closed state mechanism with no detectable binding to
open channels. At pH 7.4, its voltage-dependence points to a cation binding
site within the bilayer, near its luminal interface. At pH 9.5, the slow mech-
anism is independent of voltage, indicating that it also responds to neutral tet-
racaine molecules. Second, cytoplasmic and luminal tetracaine induce brief
closures (~1 ms- fast mechanism). It is insensitive to the open state of the
RyR, independent of voltage and markedly diminished at pH 9.5 indicating
that it is caused exclusively by tetracaine cations binding outside the trans-
membrane electric field. The action of trans-membrane pH gradients on the
fast mechanism points to a cytoplasmic location for the binding site. Finally,
cytoplasmic tetracaine reduces the ionic conductance of the channel at mM
concentrations. We predict that under diastolic conditions, the slow mecha-
nism (IC50 of ~200 mM) is a more potent form of block than the fast mech-
anism or conduction block (IC50 ~ 2mM) and these mechanisms can explain
the differences in the tetracaine inhibition seen at low and high
concentrations.
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Slow Diffusion Across Cell Membrane Delays Onset of RyR2-Channel
Block and Ca Wave Suppression by Flecainide in Intact Myocytes
Hyun Seok Hwang, Eleonora S. Galimberti, Bjorn C. Knollmann.RyR2 channel inhibitors
such as flecainide suppress
Ca waves in myocytes and
effectively prevent ventric-
ular arrhythmias in vivo.
Since the RyR2 channel is
located in an intracellular
organelle, the sarcoplasmic
reticulum, differences in
diffusion rates across the
cell membrane and gaining
access to the RyR2 may contribute to variability of drug action in intact myo-
cytes and in vivo. To test this hypothesis, we compared three RyR2 channel in-
hibitors to suppress Ca waves in permeabilized and intact myocytes: flecainide
(Flec:6mM), R-propafenone (R-prop:6mM) and tetracaine (Tetra:50mM). All
three drugs exhibited rapid onset of action in permeabilized myocytes (Figure).
In intact myocytes, only Tetra exhibited rapid onset of action, whereas Flec and
R-prop exhibited significant lag times of 10 min and 5 min, respectively (Fig-
ure). Flec’s slow onset of action in intact myocytes occurred even though its
potency was higher intact (IC50=2mM) than permeabilized myocytes
(IC50=12mM).
Conclusion: Slow diffusion of RyR2 channel blockers such as flecainide across
intact membranes importantly determines the onset of Ca wave suppression,
which has to be taken into account when evaluating drug efficacy in intact my-
oyctes and in vivo.
2255-Pos Board B241
Inhibition of Cardiac Ca2þ Release Channels by Class I Anti Arrhythmic
Drugs as Therapy for Arrhythmia
Divya R. Mehra, Dirk F. vanHelden, Bjorn C. Knollmann, Derek R. Laver.
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an arrhyth-
mia resulting from mutations in either the cardiac Ca2þ release channel (RyR2)
or calsequestrin. Flecainide is a class-Ic compound that is highly effective in
suppressing arrhythmia in CPVT patients and a calsequestrin-null mouse model
of CPVT. Its efficacy is a combination of reduced membrane excitability via its
known Naþ channel block and stabilisation of SR Ca2þ release by a recently
discovered RyR2 block. Here we report RyR2 blocking kinetics of other class
I anti arrhythmic drugs.
RyR2 was isolated from sheep and human hearts, incorporated in lipid bilayers
and investigated by single-channel recordings in presence of diastolic Ca2þ
(100 nM cytoplasmic, 0.1 mM luminal). The class 1c drugs, propafenone, fle-
cainide and encainide decreased RyR open times (IC50 = 17.35 1.6, 16.75 4
and 22.55 1.2 ı`M respectively) whereas classes Ia and Ib had no significant
effect up to 50 mM.
Blocking kinetics was also measured in fully activated RyR2 (1 mM Ca2þ, 2
mM ATP). All class I drugs tested caused voltage-dependent induction of sub-
conductance states with similar actions from luminal and cytoplasmic sides.
However, class Ic drugs produced subconductances with longer duration and
lower conductance than classes 1a and 1b. These differences may explain the
different efficacy of these drugs to curb Ca2þ release in diastole and prevent
arrhythmia.
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pends on a reduction in RyR2 open time with a short blocking duration; kinetics
typical of low affinity binding. This may lead to a paradigm shift in drug devel-
opment process by directing strategies away from discovering high affinity
compounds.
2256-Pos Board B242
Designing New Ca2þ Release Channel Inhibitors Based on Enhanced
Electron Donor Characteristics
Yanping Ye, Daniel Yaeger, Laura J. Owen, Jorge O. Escobedo, Jialu Wang,
Robert M. Strongin, Jonathan J. Abramson.
New drugs with enhanced electron donor properties that target the Ca2þ release
channel (CRC) from sarcoplasmic reticulum are potent inhibitors of single
channel activity. In this study we synthesize derivatives of the channel activator
4-chloro-3 methyl phenol (4-CmC) and the 1,4-benzothiazepine channel inhib-
itor K201 (JTV519) with enhanced electron donor properties. Instead of acti-
vating channel activity (~100 uM), 4-CmC’s 4-methoxy analog (4-methoxy-
3-methyl phenol) inhibits channel activity at sub-micromolar concentrations
(IC50 = 0.34 5 0.08 uM). Increasing the electron donor characteristics of
K201, by synthesizing its dioxole congener, results in a new compound which
is 16 times more potent an inhibitor of single channel activity (0.245 0.05 uM)
than K201(3.985 0.79 uM). These alterations to chemical structure do not af-
fect Ca2þ dependent ATPase activity of SERCA1. Both K201 and its dioxole
derivate show a similar potency toward inhibiting ATPase activity (IC50 ~50
uM), while 4-methoxy-3-methyl phenol does not inhibit ATPase activity at
concentrations up to 1 mM. Moreover, the FKBP12 protein, which stabilizes
RyR1 in a closed configuration, is shown to be a strong electron donor. It ap-
pears as if FKBP12, K201, its dioxole derivative, and 4-methoxy-3-methyl phe-
nol inhibit the skeletal muscle SR CRC channel activity by virtue of their
electron donor characteristics. We also show that the inhibitory action of
K201 is independent of FKBP12 binding to RyR1. These results embody strong
evidence that designing new drugs that target the CRC with enhanced electron
donor characteristics results in more potent channel inhibitors. This represents
a novel approach toward designing new more potent drugs aimed at function-
ally modifying the CRC from sarcoplasmic reticulum. Supported by PSU Fac-
ulty Development Award, University Venture Development Fund, ONAMI,
and NIH (R01 AR48911) to JJA.
2257-Pos Board B243
Altered Ca2þ Sensitivity and Gating Properties of Skeletal Muscle Ryano-
dine Receptors in Aged Mice
Albano C. Meli, Steve Reiken, Ran Zalk, Daniel C. Andersson,
Matthew J. Betzenhauser, Andrew R. Marks.
Calcium (Ca2þ) release channel/ryanodine receptor 1 (RyR1) plays a funda-
mental role in the transient increase of cytosolic free Ca2þ upon depolarization
of transverse tubules in skeletal fast-switch muscles.
Sarcopenia can be defined as the age-related loss of muscle mass, strength and
function. Using an animal model of sarcopenia, we found that fast-switch mus-
cle RyR1 from aged mice (24 months) compared to younger mice (3-6 months)
was oxidized, cysteine-nitrosylated, and depleted of the channel stabilizing
subunit FK506 binding protein (FKBP12 or calstabin1). Such modifications
of the RyR1 macromolecular complex are known to impair RyR1 channel
activity.
Here, we looked at the single-channel properties of RyR1 in young and aged
mice using RyR1 agonists (calcium, ATP, caffeine). Age-related changes in
RyR1 Ca2þ sensitivity were manifested by an increased open probability
(Po), particularly at low activating calcium concentration (e.g., 150 nM). In-
creased Po was associated with an increased opening frequency (Fo) while
the mean open-time (To) was unchanged. The concentration-response curve
for calcium dependent activation for RyR1 from aged muscle was left shifted.
These data suggest that RyR1 may be ‘‘leaky’’ in skeletal muscle from aged
mice.
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Investigating the Functional Dynamics of Bacterial Chemoreceptors Using
Hydrogen Exchange Mass Spectrometry
Seena S. Koshy, Stephen J. Eyles, Robert M. Weis, Lynmarie K. Thompson.
Bacterial chemotaxis is an ideal system to study the underlying mechanisms
involved in transmembrane signaling and signal processing. Bacteria such as
E. coli sense chemicals through chemoreceptors, and transmit information
from the periplasmic space to the cytosol, to ultimately control the swimming
direction of the cell. Chemoreceptors function as large multimeric complexes
that also contain a histidine kinase (CheA) and an adaptor protein (CheW).
Previously, we and others have shown that the cytoplasmic domain of the re-ceptor is highly dynamic, and small changes in a few amino acids can dramat-
ically stabilize this domain. To investigate whether modulation of
cytoplasmic domain dynamics plays a role in the signaling mechanism, we
have developed a mass spectrometry method to measure hydrogen exchange
of the cytoplasmic domain in active, membrane-bound complexes with CheA
and CheW. Our global dynamics data clearly shows that cytoplasmic domain
dynamics are significantly reduced in active complexes relative to the non-
functional solution state. Current efforts to optimize pepsin digest conditions
will enable us to determine whether local dynamics change with signaling
state, to provide insight into the role of dynamics in the transmembrane sig-
naling mechanism.
This research supported by GM 47601, GM085288, and a Fellowship to Seena
Koshy from the University of Massachusetts as part of the Chemistry-Biology
Interface Training Program (NRSA T32 GM08515 ).
2259-Pos Board B245
Conformational Changes during Kinase On-Off Switching in the Chemo-
sensory Signaling Array of the Bacterial Cell Membrane: Detection by
One-Sample FRET
Annette H. Erbse, Adam J. Berlinberg, Joseph J. Falke.
Fluorescence resonance energy transfer (FRET) is a powerful tool to study
macromolecular assemblies in vitro under near physiological conditions.
One Sample FRET (OS-FRET) employs a novel, non-fluorescent
methanethiosulfonate-linked acceptor that can be reversibly coupled to a target
protein Cys residue (Erbse et al, submitted). The design of OS-FRET provides
distinct advantages over existing methods for quantitative FRETmeasurements
in virtually any fluorimeter or detection device. We previously demonstrated
the utility of the method by applying it to a soluble complex formed by the
CheA and CheW proteins of the bacterial chemosensory pathway. Here, OS-
FRET is applied to the functional, membrane-bound bacterial chemosensory
signaling array. OS-FRET reveals that attractant binding to transmembrane
chemoreceptors triggers large, relative domain motions in the CheA kinase pro-
teins of the signaling array. These findings provide the first molecular view of
the structural changes underlying receptor-mediated kinase on-off switching in
bacterial chemosensing.
[Supported by NIH grant GM040731]
2260-Pos Board B246
The Energy Cost of Sensory Adaptation
Ganhui Lan, Pablo Sartori, Yuhai Tu.
Biological sensory systems adapt to prolonged stimuli in order to maintain high
sensitivity in different environments. Sensory adaptations are carried out by
various molecular feedback mechanisms.
Here, we show that all adaptation dynamics
are dissipative and feedback control con-
sumes energy to achieve high adaptation ac-
curacy against intrinsic fluctuations in the
underlying molecular signaling pathways.
A universal relation among energy dissipa-
tion rate, adaptation time, and the optimum
adaptation accuracy is established in a gen-
eral continuum model and for the specific
case of adaptation in E. coli chemotaxis.
Our study finds that sensory adaptations are
fueled by high-energy biomolecules (e.g.,
ATP), which provide the energy necessary
in stabilizing the adapted state. For E. coli chemotaxis, hydrolysis of S-adeno-
sylmethionine (SAM) drives the chemo-receptor adaptation, and the high en-
ergy content in SAM is crucial in maintaining the near perfect adaptation of
the system. Finally, we point out that the energy-accuracy relation found
here has deep connections with the energy dissipation required for molecular
level error-correction and information processing.
2261-Pos Board B247
Increases in Amplitude and Frequency of Ciliary Beating by a b2-Agonist,
Procaterol, in Small Airways of Mice
Takashi Nakahari.
The beat frequency (CBF) and the beat angle (CBA) of mice small airway cilia
were measured using a light microscope equipped with a high-speed camera
(500 Hz). This study demonstrated that a b2-agonist, procaterol, increases
not only CBF but also CBA in small airways and that an increase in CBA en-
hances the rate of mucociliary transport. A low concentration of procaterol (1-
10 pM) increased CBA by ~30%, but not CBF, whereas a high concentration
(10 nM) increased both CBA and CBF by ~100%. Procaterol actions were
mimicked by forskolin (FK) and isobutyl-methylxanthine (IBMX) and
